Anavex Life Sciences Corp (AVXL)

[rayovacAAA]

NTRP RELEASED THEIR "BAD NEWS" ON 9 SEPTEMBER 2019, NOT 5 SEPTEMBER.

It appears they got the data about July 15 and released the bad news on September 5.

https://neurotrope.com/neurotrope-announces-top-line-results-from-confirmatory-phase-2-study-of-bryostatin-1-in-moderate-to-severe-alzheimers-disease/

NEW YORK, Sept. 9, 2019 /PRNewswire/ — Neurotrope, Inc. (Nasdaq: NTRP), a clinical-stage biopharmaceutical company developing novel therapies for neurodegenerative diseases, including Alzheimer’s disease (AD), today announced that its confirmatory Phase 2 study of Bryostatin-1 in moderate to severe AD did not achieve statistical significance on the primary endpoint, which was change from baseline to Week 13 in the Severe Impairment Battery (SIB) total score.